SAN FRANCISCO, January 15, 2018 /PRNewswire/ --
The global human growth hormone (hGH) market is expectedto reach USD 7.1 billion by 2025, according to a new report by Grand View Research, Inc. Rising cases of pituitary dysfunction and increasing use of human growth hormone are likely to drive the market in coming years.
Turner syndrome, growth hormone deficiency, Prader-Willi syndrome, idiopathic short stature, and small for gestational age (SGA) are major disorders in which growth hormone (GH) are used. Additionally, growth hormone also received an approval for other indications such as Creutzfeldt-Jakob disease, chronic kidney disease, SHOX gene haploinsufficiency, and Noonan syndrome.
Although FDA has not approved the use of hGH as anti-aging therapy, many practitioners offer injections of growth hormones at higher prices. The hGH therapy is aggressively promoted for advanced age symptoms.
hGH is anabolic as it accelerates protein synthesis and breaks down fat. Hence, athletes involved in strength demanding activities and sports are likely to use growth hormones for its anabolic effects. It is a fairly common practice among athletes and body-builders to use combination of anabolic steroids and GH for the benefits.
Browse full research report with TOC on "Human Growth Hormone (hGH) Market Analysis By Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, SGA), By Region, And Segment Forecasts, 2014 - 2025" at: https://www.grandviewresearch.com/industry-analysis/human-growth-hormone-drugs-market
Further Key Findings From the Report Suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the global human growth hormone market on the basis of application and region:
Read Our Blog By Grand View Research: https://www.grandviewresearch.com/blogs/healthcare
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email: firstname.lastname@example.org
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...View All